Yi Ping Rong
Fortune : 48 259 $ au 30/06/2026
Fortune : 48 259 $ au 30/06/2026
Yi Ping Rong is Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd. since 2016.
Dr. Rong is Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd. since 2022.
Former roles include Member at The American Association of Cancer Research.
Education includes a doctorate from Case Western Reserve University conferred in 2008 and a graduate degree from East China University of Science & Technology conferred in 2002.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/09/2025 | 36 250 ( 0 % ) | 48 259 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HBM HOLDINGS LIMITED | Directeur Technique/Scientifique/R&D | 05/05/2022 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
The American Association of Cancer Research | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
The American Association of Cancer Research |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national